Both p53 and NF-κB share important roles in human cancers, especially cancers resulting from the chronic inflammation, such as colorectal cancer and renal cell carcinoma, wherein the inactivation of the p53 and NF-κB hyperactivation is a common occurrence [47]. Here, TP53 is linked to hereditary clear cell renal cell carcinoma.